The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.
The grant focuses on the analytical validation of candidate biomarkers for neurological diseases and conditions. Its primary aim is to support the rigorous validation of analytical methods for biomarker measurements. This includes evaluating the detection method, its performance characteristics, and identifying the optimal conditions for reproducibility and accuracy in line with FDA guidelines. The grant assumes that a biomarker has already been identified, a detection method technology has been developed, and the research or clinical need, along with the potential context of use, has been clearly established.